1585 related articles for article (PubMed ID: 11257029)
1. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.
Yigit H; Queenan AM; Anderson GJ; Domenech-Sanchez A; Biddle JW; Steward CD; Alberti S; Bush K; Tenover FC
Antimicrob Agents Chemother; 2001 Apr; 45(4):1151-61. PubMed ID: 11257029
[TBL] [Abstract][Full Text] [Related]
2. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2.
Yigit H; Queenan AM; Rasheed JK; Biddle JW; Domenech-Sanchez A; Alberti S; Bush K; Tenover FC
Antimicrob Agents Chemother; 2003 Dec; 47(12):3881-9. PubMed ID: 14638498
[TBL] [Abstract][Full Text] [Related]
3. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
Cai JC; Zhou HW; Zhang R; Chen GX
Antimicrob Agents Chemother; 2008 Jun; 52(6):2014-8. PubMed ID: 18332176
[TBL] [Abstract][Full Text] [Related]
4. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli.
Nordmann P; Mariotte S; Naas T; Labia R; Nicolas MH
Antimicrob Agents Chemother; 1993 May; 37(5):939-46. PubMed ID: 8517720
[TBL] [Abstract][Full Text] [Related]
5. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae.
Poirel L; Héritier C; Tolün V; Nordmann P
Antimicrob Agents Chemother; 2004 Jan; 48(1):15-22. PubMed ID: 14693513
[TBL] [Abstract][Full Text] [Related]
6. Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae.
Kitchel B; Rasheed JK; Endimiani A; Hujer AM; Anderson KF; Bonomo RA; Patel JB
Antimicrob Agents Chemother; 2010 Oct; 54(10):4201-7. PubMed ID: 20660684
[TBL] [Abstract][Full Text] [Related]
7. Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae.
Lomovskaya O; Sun D; Rubio-Aparicio D; Nelson K; Tsivkovski R; Griffith DC; Dudley MN
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848018
[TBL] [Abstract][Full Text] [Related]
8. [Detection of plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in a strain of carbapenem-resistant Enterobacter cloacae].
Cai JC; Zhou HW; Chen GX; Zhang R
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):135-8. PubMed ID: 18353225
[TBL] [Abstract][Full Text] [Related]
9. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe.
Kaczmarek FM; Dib-Hajj F; Shang W; Gootz TD
Antimicrob Agents Chemother; 2006 Oct; 50(10):3396-406. PubMed ID: 17005822
[TBL] [Abstract][Full Text] [Related]
10. The efflux pump inhibitor phenylalanine-arginine β-naphthylamide (PAβN) increases resistance to carbapenems in Chilean clinical isolates of KPC-producing Klebsiella pneumoniae.
Vera-Leiva A; Carrasco-Anabalón S; Lima CA; Villagra N; Domínguez M; Bello-Toledo H; González-Rocha G
J Glob Antimicrob Resist; 2018 Mar; 12():73-76. PubMed ID: 29275225
[TBL] [Abstract][Full Text] [Related]
11. Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France.
Naas T; Nordmann P; Vedel G; Poyart C
Antimicrob Agents Chemother; 2005 Oct; 49(10):4423-4. PubMed ID: 16189140
[No Abstract] [Full Text] [Related]
12. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
[TBL] [Abstract][Full Text] [Related]
13. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.
Woodford N; Tierno PM; Young K; Tysall L; Palepou MF; Ward E; Painter RE; Suber DF; Shungu D; Silver LL; Inglima K; Kornblum J; Livermore DM
Antimicrob Agents Chemother; 2004 Dec; 48(12):4793-9. PubMed ID: 15561858
[TBL] [Abstract][Full Text] [Related]
14. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
Bradford PA; Urban C; Mariano N; Projan SJ; Rahal JJ; Bush K
Antimicrob Agents Chemother; 1997 Mar; 41(3):563-9. PubMed ID: 9055993
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Park YJ; Yu JK; Park KG; Park YG; Lee S; Kim SY; Jeong SH
Diagn Microbiol Infect Dis; 2011 Sep; 71(1):87-9. PubMed ID: 21397426
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
17. High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.
Rice LB; Carias LL; Hujer AM; Bonafede M; Hutton R; Hoyen C; Bonomo RA
Antimicrob Agents Chemother; 2000 Feb; 44(2):362-7. PubMed ID: 10639363
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates.
Kim SY; Park YJ; Yu JK; Kim HS; Park YS; Yoon JB; Yoo JY; Lee K
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):85-91. PubMed ID: 16854555
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18.
Rasheed JK; Anderson GJ; Yigit H; Queenan AM; Doménech-Sánchez A; Swenson JM; Biddle JW; Ferraro MJ; Jacoby GA; Tenover FC
Antimicrob Agents Chemother; 2000 Sep; 44(9):2382-8. PubMed ID: 10952583
[TBL] [Abstract][Full Text] [Related]
20. Expression of SHV-2 beta-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems.
Crowley B; Benedí VJ; Doménech-Sánchez A
Antimicrob Agents Chemother; 2002 Nov; 46(11):3679-82. PubMed ID: 12384391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
